檢索結果 - Sarah Demortière

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

    Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond? 由 Adil Maarouf, Audrey Rico, Clémence Boutière, Marine Perriguey, Sarah Demortière, Jean Pelletier, Bertrand Audoin

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab

    Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab 由 Marine Perriguey, Adil Maarouf, Jan‐Patrick Stellmann, Audrey Rico, Clémence Boutière, Sarah Demortière, Pierre Durozard, Jean Pelletier, Bertrand Audoin

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis

    Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis 由 Roxane Claverie, Marine Perriguey, Audrey Rico, Clémence Boutière, Sarah Demortière, Pierre Durozard, Frédéric Hilezian, Cléa Dubrou, Frédéric Vely, Jean Pelletier, Bertrand Audoin, Adil Maarouf

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis

    Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis 由 Mélany Venet, Anne Lépine, Adil Maarouf, Damien Biotti, Clémence Boutière, Olivier Casez, Mikaël Cohen, Pierre Durozard, Sarah Demortière, Laetitia Giorgi, Élisabeth Maillart, Guillaume Mathey, Laure Mazzola, Audrey Rico, Jean‐Philippe Camdessanché, Kumaran Deiva, Jean Pelletier, Bertrand Audoin

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: